Publications

Sort by: Date | Author | Title

Mipatrini, D., Montaldo, C., Bartolini, B., Rezza, G., Iavicoli, S., Ippolito, G., Zumla, A. & Petersen, E. (2022). 'Disease X'-time to act now and prepare for the next pandemic threat. European Journal of Public Health, 32(6), 841-842. https://doi.org/10.1093/eurpub/ckac151
Gruell, H., Gunst, J. D., Cohen, Y. Z., Pahus, M. H., Malin, J. J., Platten, M., Millard, K. G., Tolstrup, M., Jones, R. B., Conce Alberto, W. D., Lorenzi, J. C. C., Oliveira, T. Y., Kümmerle, T., Suárez, I., Unson-O'Brien, C., Nogueira, L., Olesen, R., Østergaard, L., Nielsen, H. ... Søgaard, O. S. (2022). Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial. The Lancet Microbe, 3(3), e203-e214. https://doi.org/10.1016/S2666-5247(21)00239-1
Petersen, E., Ntoumi, F., Hui, D. S., Abubakar, A., Kramer, L. D., Obiero, C., Tambyah, P. A., Blumberg, L., Yapi, R., Al-Abri, S., Pinto, T. D. C. A., Yeboah-Manu, D., Haider, N., Asogun, D., Velavan, T. P., Kapata, N., Bates, M., Ansumana, R., Montaldo, C. ... Zumla, A. (2022). Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts. International Journal of Infectious Diseases, 114, 268-272. https://doi.org/10.1016/j.ijid.2021.11.040
Oriol-Tordera, B., Esteve-Codina, A., Berdasco, M., Rosás-Umbert, M., Gonçalves, E., Duran-Castells, C., Català-Moll, F., Llano, A., Cedeño, S., Puertas, M. C., Tolstrup, M., Søgaard, O. S., Clotet, B., Martínez-Picado, J., Hanke, T., Combadiere, B., Paredes, R., Hartigan-O'Connor, D., Esteller, M. ... Ruiz-Riol, M. (2022). Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome. EBioMedicine, 78, Article 103956. https://doi.org/10.1016/j.ebiom.2022.103956
Johansen, N. D., Modin, D., Nealon, J., Samson, S., Salamand, C., Larsen, C. S., Claggett, B. L., Solomon, S. D., Landray, M. J., Gislason, G. H., Køber, L., Jensen, J. U. S., Sivapalan, P., Vestergaard, L. S., Valentiner-Branth, P., Krause, T. G. & Biering-Sørensen, T. (2022). Feasibility of randomizing Danish citizens aged 65–79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial. Pilot and Feasibility Studies, 8(1), Article 87. https://doi.org/10.1186/s40814-022-01044-w
Suppli, C. H., Norman, A., Folkvardsen, D. B., Gissel, T. N., Weinreich, U. M., Koch, A., Wejse, C. & Lillebaek, T. (2022). First outbreak of multi-drug resistant tuberculosis (MDR-TB) in Denmark involving six Danish-born cases. International Journal of Infectious Diseases, 117, 258-263. https://doi.org/10.1016/j.ijid.2022.02.017